Patents Examined by Lori L. Yuan
  • Patent number: 5284749
    Abstract: Assay for detection of a form of diamine oxidase which is present only in amniotic fluid and, more especially, for detection of amniotic membrane rupture by detection of the amniotic fluid diamine oxidase. The assay includes the steps of detecting the amniotic fluid diamine oxidase and distinguishing that from another form of diamine oxidase found in serum. The assay may be carried out on a sample of vaginal fluid from a pregnant female wherein the sample is subjected to the assay to detect the leakage or presence of amniotic fluid diamine oxidase. Purified forms of amniotic fluid diamine oxidase and serum diamine oxidase which is different from amniotic fluid diamine oxidase and found in serum are also described, together with a method of purifying both forms of diamine oxidase.
    Type: Grant
    Filed: October 31, 1990
    Date of Patent: February 8, 1994
    Assignee: Griffith University
    Inventors: David M. Cowley, David J. Maguire, Victor Voroteliak
  • Patent number: 5213830
    Abstract: Method for quality control of meat products, especially fish flesh, with regard to the presence of worms. The product to be subjected to quality control, or a sample thereof, is exposed to electromagnetic radiation within the range of about 800-1800 nm, and the irradiation transmitted through said product or sample as a result of this irradiation, is analyzed for identification of characteristic absorption by worms in said product or sample.
    Type: Grant
    Filed: June 19, 1990
    Date of Patent: May 25, 1993
    Assignee: Lumetech
    Inventors: Peter Haagensen, Alicia de Francisco, Lars Munck
  • Patent number: 5192659
    Abstract: The present invention provides a method for detection of at least one allele of a genetic locus and can be used to provide direct determination of the haplotype. The method comprises amplifying genomic DNA with a primer pair that spans an intron sequence and defines a DNA sequence in genetic linkage with an allele to be detected. The primer-defined DNA sequence contains a sufficient number of intron sequence nucleotides to characterize the allele. Genomic DNA is amplified to produce an amplified DNA sequence characteristic of the allele. The amplified DNA sequence is analyzed to detect the presence of a genetic variation in the amplified DNA sequence such as a change in the length of the sequence, gain or loss of a restriction site or substitution of a nucleotide. The variation is characteristic of the allele to be detected and can be used to detect remote alleles. Kits comprising one or more of the reagents used in the method are also described.
    Type: Grant
    Filed: July 11, 1990
    Date of Patent: March 9, 1993
    Assignee: GeneType AG
    Inventor: Malcolm J. Simons
  • Patent number: 5091518
    Abstract: The present invention provide transcriptional control regions, expression vectors comprising said regions, mammalian cells transformed to transcribe and express genes from said vectors, and various methods of assaying compounds for hormone agonist or antagonist activity, all based on discovery of response elements of the .beta.-retinoic acid receptor and of the activation of said response elements in all mammalian cells without need to transform the cells to express the receptor independently of endogenous expression thereof.
    Type: Grant
    Filed: November 16, 1989
    Date of Patent: February 25, 1992
    Assignee: The Salk Institute for Biological Studies
    Inventors: Henry M. Sucov, Ronald M. Evans